 |
|
Cerebral White Matter Lesions and the Risk of Dementia
Niels D. Prins, MD, PhD;
Ewoud J. van Dijk, MD;
Tom den Heijer, MD;
Sarah E. Vermeer, MD, PhD;
Peter J. Koudstaal, MD, PhD;
Matthijs Oudkerk, MD, PhD;
Albert Hofman, MD, PhD;
Monique M. B. Breteler, MD, PhD
Arch Neurol. 2004;61:1531-1534.
ABSTRACT
| |
Objective To study the association between white matter lesions (WML) in specific locations and the risk of dementia.
Design The Rotterdam Scan Study, a prospective population-based cohort study. We scored periventricular and subcortical WML on magnetic resonance imaging and observed participants until January 2002 for incident dementia.
Setting General population.
Participants We included 1077 people aged 60 to 90 years who did not have dementia at baseline.
Main Outcome Measure Incident dementia by Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM III-R) criteria.
Results During a mean follow-up of 5.2 years, 45 participants developed dementia. Higher severity of periventricular WML increased the risk of dementia, whereas the association between subcortical WML and dementia was less prominent. The adjusted hazard ratio of dementia for each standard deviation increase in periventricular WML severity was 1.67 (95% confidence interval, 1.25-2.24). This increased risk was independent of other risk factors for dementia and partly independent of other structural brain changes on magnetic resonance imaging.
Conclusion White matter lesions, especially in the periventricular region, increase the risk of dementia in elderly people.
INTRODUCTION
Cerebral white matter lesions (WML) in elderly people are thought to result from small-vessel disease and are considered to be a risk factor for dementia.1 Evidence relating WML to dementia is mainly derived from studies in patients with stroke and fromcross-sectional studies in patients with dementia. White matter lesions increase the risk of poststroke dementia and, together with lacunar infarcts, are considered the primary type of brain lesions in subcortical ischemic vascular dementia.1-2 Small-vessel disease may also contribute to the development of Alzheimer disease (AD), because patients with AD were found to have more WML than controls.3
White matter lesions are also frequently seen on magnetic resonance (MR) imaging of elderly patients without dementia, but only a few studies investigated the extent to which WML increase the risk of dementia in the general population.4-5 We investigated the risk of dementia for WML in specific locations in the Rotterdam Scan Study. Furthermore, we assessed whether the association between WML and dementia is independent of other risk factors for dementia and other structural brain changes on MR imaging.
METHODS
STUDY POPULATION
The Rotterdam Scan Study is a prospective, population-based cohort study designed to study causes and consequences of age-related brain changes in elderly people. The characteristics of the 1077 participants have been described previously.6 All participants were free of dementia at baseline.5 Baseline examination from 1995 to 1996 comprised a structured interview, neuropsychological tests, physical examination, and blood sampling; all participants underwent MR imaging of the brain. From 1999 to 2000, 787 of the 973 participants who were alive and eligible were reexamined at the research center similar to the baseline examination (response rate, 81%). All participants were continually monitored for mortality, dementia, and stroke until January 1, 2002.
MR IMAGING PROCEDURE
Details of the MR imaging examinations in the Rotterdam Scan Study have been published.6 We considered WML to be in the periventricular region if they were directly adjacent to the ventricle; otherwise, we considered them subcortical. Periventricular WML were scored semiquantitatively for locations at the frontal and occipital horns, and the lateral walls of the ventricles, in order to obtain a total periventricular score (range, 0-9). For subcortical WML, a total volume as appearing on hardcopy was approximated based on the number and size of lesions in the frontal, parietal, temporal, and occipital lobes (range, 0-29.5 mL).6 We rated cortical atrophy on a semiquantitive scale (range, 0-15) and assessed subcortical atrophy by the ventricle to brain ratio (range, 0.21-0.45). Cerebral infarcts were defined as focal hyperintensities on T2-weighted images, 3 mm or larger, and with a corresponding prominent hypointensity on T1-weighted images if located in the white matter.5
ASCERTAINMENT OF INCIDENT DEMENTIA
Participants with dementia were carefully excluded at baseline.5 We screened all participants for dementia at follow-up with the Mini-Mental State Examination (MMSE),7 and the Geriatric Mental State Schedule8 Screen positives were subsequently evaluated using the Cambridge Mental Disorders of the Elderly Examination.9 Participants who were then thought to have dementia were examined by a neurologist and underwent extensive neuropsychological testing. In addition, we continually monitored the medical records of all participants at their general practitioners’ offices and at the Regional Institute for Outpatient Mental Health Care to obtain information on newly diagnosed dementia until January 1, 2002.5 A panel that reviewed all available information diagnosed dementia and its subtypes according to standardized criteria.10-12 We defined the onset of dementia as the date on which the clinical symptoms first allowed the diagnosis of dementia to be made.
OTHER BASELINE MEASUREMENTS
The following variables assessed at baseline were used as possible confounders: age, sex, educational status,13 hypertension, diabetes mellitus, smoking, APOE genotype,14 history of stroke, and incident stroke.5
DATA ANALYSIS
We assessed the association between WML and measures of generalized brain atrophy with Pearson correlation coefficient, and the association between WML and the presence of cerebral infarcts with linear regression analysis. To examine the relationship between WML and the risk of dementia and AD, we used Cox proportional hazards regression models. We analyzed periventricular and subcortical WML in categories of severity to analyze the shape of the relationship and as a continuous variable (per standard deviation). Adjustments were made for age and sex, and analyses were repeated with possible confounders and measures of other structural brain changes added to the models. Additionally, we excluded participants with a history of stroke at baseline, and participants with a baseline MMSE score of 25 or lower. We examined possible effect modification by APOE genotype through stratified analysis.
RESULTS
Characteristics of the participants are presented in Table 1. Periventricular and subcortical WML were positively correlated with cortical brain atrophy (Pearson correlation coefficient 0.40, P<.01 and 0.25, P<.01) and subcortical brain atrophy (Pearson correlation coefficient 0.21, P<.01 and 0.14, P<.01). Presence of cerebral infarcts was associated with a higher severity of periventricular and subcortical WML (age- and sex-adjusted mean difference in periventricular WML severity 1.6 points, 95% confidence interval [CI], 1.3-1.9 points; in subcortical WML severity 2.0 mL; 95% CI, 1.6-2.4 mL).
|
|
|
|
Table 1. Baseline Characteristics of Participants of the Rotterdam Scan Study*
|
|
|
During 5572 person-years of follow-up (mean per person, 5.2 years), 45 participants developed dementia (incidence rate, 8.1/1000 person-years). Alzheimer disease was diagnosed in 34 patients (76%), vascular dementia in 6 (13%), and another 5 (11%) were diagnosed as having other types of dementia (Parkinson disease dementia [3], multiple system atrophy [1], and unspecified dementia [1]). One hundred seventy-four participants died. The risk of dementia increased linearly with severity of periventricular WML (Figure 1 and Table 2). Increasing severity of subcortical WML tended to increase the risk of dementia, but this association was less strong (Figure 1 and Table 2). The hazard ratio for dementia per standard deviation increment in periventricular WML score remained largely the same after exclusion of participants with a history of stroke (n = 58) (hazard ratio for dementia 1.66; 95% CI, 1.22-2.27) and after adjustment for incident stroke (hazard ratio for dementia, 1.63; 95% CI, 1.21-2.19). After exclusion of participants with a baseline MMSE score of 25 or lower (n = 173), the association remained (hazard ratio for dementia, 1.50; 95% CI, 1.04-2.16).
|
|
|
|
Figure 1. Severity of white matter lesions (WML) is divided into 3 categories based on the distribution of periventricular WML scores. The risk of dementia is expressed as age- and sex-adjusted hazard ratios. The number of dementia cases and total number of participants, respectively, in consecutive periventricular WML severity categories were 16 and 749 (grade 0-3), 18 and 261 (grade >3-6), 11 and 66 (grade >6-9), and in consecutive subcortical WML severity categories 24 and 763 (0-1 mL), 10 and 244 (>1-6 mL), and 10 and 65 (>6-29.5 mL).
|
|
|
|
|
|
|
Table 2. Relation Between the Severity of Periventricular and Subcortical White Matter Lesions and the Risk of Dementia*
|
|
|
Participants who developed dementia during follow-up had on average more severe WML at baseline in all locations within the periventricular and subcortical region (Figure 2). Periventricular WML also increased the risk of AD (hazard ratio for AD, 1.41; 95% CI, 1.01-1.98). The association of periventricular WML and AD was similar for those with and without an APOE  4 allele (data not shown).
|
|
|
|
Figure 2. Bars represent age- and sex-adjusted mean white matter lesion severity (standard error) at baseline for participants without (n = 1032) and participants with (n = 45) incident dementia during follow-up.
|
|
|
COMMENT
Higher severity of periventricular WML increased the risk of dementia, whereas the association between subcortical WML and dementia was less prominent. The association between periventricular WML and dementia was independent of possible confounders and partly independent of other structural brain changes on MR imaging. The strengths of this study are the large number of participating elderly people, its population-based design, and the fact that we had a complete follow-up for dementia through our monitoring system. Another important feature is the distinction between WML in the periventricular region and WML in the subcortical region.
A preclinical phase of many years often precedes a diagnosis of dementia, especially in the case of AD.15 It is therefore likely that our study population contained participants with a preclinical stage of dementia that remained below detection at baseline. The association of periventricular WML and the risk of dementia did not change after exclusion of participants with a low MMSE score at baseline, which suggests that the association is not confined to participants with a preclinical stage of dementia.
Our results are in line with those from previous studies on the relationship between WML and dementia. Cross-sectional case-control studies reported positive associations of the severity of WML on MR imaging with AD and vascular dementia.3, 16 In the Cardiovascular Health Study, participants with more severe WML had a 2-fold increased risk of dementia.4
Several potential mechanisms may underlie the observed associations between WML and dementia. Histopathological studies demonstrated that irregular and confluent WML correspond to ischemic tissue damage, including infarction, gliosis and rarefaction, and loss of myelin.17 This tissue damage is likely to cause disconnection of functionally related cortical and subcortical structures that are important to cognitive functioning.18 It has been suggested that periventricular WML are just an epiphenomenon of brain atrophy and are not independently related to disease.19-20 We found that the association between periventricular WML and the risk of dementia was partly independent of generalized brain atrophy. Furthermore, we found that the association between periventricular WML and incident dementia was largely independent of the presence of cerebral infarcts, of which the majority were lacunar in our study, and was not mediated by incident stroke.
Subcortical WML were not as strongly associated with dementia as periventricular WML, which is in line with previous reports.3 Several possible pathophysiologic mechanisms may explain this finding. First, WML close to the ventricles may interrupt bundles of cholinergic fibers, which extend from the nucleus basalis to the cerebral cortex, resulting in cholinergic denervation.21 Second, the white matter in the periventricular region has a high density of long association fibers, whereas subcortical white matter has a high density of U-fibers. Diffusion tensor MR imaging studies found that white matter pathologic features in patients with AD selectively involved fiber tracts connecting cortical association areas, such as the cingulate bundles and the corpus callosum.22-23 Periventricular WML may reflect vascular damage to these fiber tracts or, alternatively, represent wallerian degeneration of these tracts.
Extensive WML alone are sufficient for a diagnosis of vascular dementia,12 which leads to circularity when associations between WML and subdiagnoses of dementia are studied. However, the observed association between periventricular WML and AD suggests that WML may contribute to clinical AD. This is compatible with the view that most elderly people with dementia have mixed disease.24 Because of the small number of cases with vascular dementia, we cannot provide reliable estimates for the association between WML and the risk of vascular dementia. In conclusion, we found that higher severity of periventricular WML is independently associated with an increased risk of dementia. Longer follow-up with repeated MR imaging is needed to gain insight into whether, and to what extent, progression of WML increases the risk of dementia.
AUTHOR INFORMATION
Correspondence: Monique M. B. Breteler, MD, PhD, Department of Epidemiology and Biostatistics, Erasmus Medical Center, PO Box 1738, 3000 DR Rotterdam, the Netherlands (m.breteler{at}erasmusmc.nl).
Accepted for Publication: November 25, 2003.
Author Contributions: Study concept and design (Drs Prins, van Dijk, Vermeer, Koudstaal, Hofman, and Breteler); acquisition of data (Drs Prins, van Dijk, den Heijer, Vermeer, and Oudkerk); analysis and interpretation of data (Drs Prins, van Dijk, den Heijer, Koudstaal, Oudkerk, Hofman, and Breteler); drafting of the manuscript (Drs Prins, van Dijk, Hofman, and Breteler); critical revision of the manuscript for important intellectual content (Drs Prins, den Heijer, Vermeer, Koudstaal, Oudkerk, Hofman, and Breteler); statistical expertise (Drs Prins, van Dijk, and Breteler); obtained funding (Drs Koudstaal, Oudkerk, and Breteler); administrative, technical, and material support (Drs Prins, van Dijk, Vermeer, and Oudkerk); study supervision (Drs Koudstaal, Oudkerk, Hofman, and Breteler).
Funding/Support: This study was supported by grants from the Netherlands Organization for Scientific Research (904.61.096), Den Haag.
Acknowledgment: We thank the Regional Institute for Ambulatory Mental Health Care, Rotterdam and Voorburg, and the general practitioners of Rotterdam and Zoetermeer for their collaboration.
Author Affiliations: Departments of Epidemiology and Biostatistics (Drs Prins, van Dijk, den Heijer, Vermeer, Hofman, and Breteler) and Neurology (Drs Prins, van Dijk, den Heijer, Vermeer, and Koudstaal), Erasmus Medical Center, Rotterdam, the Netherlands; and the Department of Radiology, University Hospital Groningen, Groningen, the Netherlands (Dr Oudkerk).
REFERENCES
| |
1. Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002;1:426-436.
FULL TEXT
|
ISI
| PUBMED
2. Leys D, Henon H, Pasquier F. White matter changes and poststroke dementia. Dement Geriatr Cogn Disord. 1998;9(suppl 1):25-29.
3. O’Brien JT, Ames D. White matter lesions in depression and Alzheimer’s disease. Br J Psychiatry. 1996;169:671.
4. Kuller LH, Lopez OL, Newman A, et al. Risk factors for dementia in the cardiovascular Health Cognition Study. Neuroepidemiology. 2003;22:13-22.
FULL TEXT
|
ISI
| PUBMED
5. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348:1215-1222.
FREE FULL TEXT
6. de Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol. 2000;47:145-151.
FULL TEXT
|
ISI
| PUBMED
7. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state.". J Psychiatr Res. 1975;12:189-198.
FULL TEXT
|
ISI
| PUBMED
8. Copeland JR, Kelleher MJ, Kellett JM, et al. A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly. Psychol Med. 1976;6:439-449.
ISI
| PUBMED
9. Roth M, Tym E, Mountjoy CQ, et al. CAMDEX. Br J Psychiatry. 1986;149:698-709.
FREE FULL TEXT
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.
11. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease. Neurology. 1984;34:939-944.
FREE FULL TEXT
12. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Neurology. 1993;43:250-260.
FREE FULL TEXT
13. UNESCO. International Standard Classification of Education (ISCED). Paris, France: UNESCO; 1976.
14. Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 1991;337:1158-1159.
ISI
| PUBMED
15. Elias MF, Beiser A, Wolf PA, Au R, White RF, D’Agostino RB. The preclinical phase of alzheimer disease. Arch Neurol. 2000;57:808-813.
FREE FULL TEXT
16. Barber R, Scheltens P, Gholkar A, et al. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry. 1999;67:66-72.
FREE FULL TEXT
17. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis. Stroke. 1997;28:652-659.
FREE FULL TEXT
18. Filley CM. The behavioral neurology of cerebral white matter. Neurology. 1998;50:1535-1540.
ABSTRACT
19. Fazekas F, Kapeller P, Schmidt R, Offenbacher H, Payer F, Fazekas G. The relation of cerebral magnetic resonance signal hyperintensities to Alzheimer’s disease. J Neurol Sci. 1996;142:121-125.
FULL TEXT
|
ISI
| PUBMED
20. Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, O’Brien JT. MRI volumetric correlates of white matter lesions in dementia with Lewy bodies and Alzheimer’s disease. Int J Geriatr Psychiatry. 2000;15:911-916.
FULL TEXT
|
ISI
| PUBMED
21. Selden NR, Gitelman DR, Salamon-Murayama N, Parrish TB, Mesulam MM. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain. 1998;121:2249-2257.
FREE FULL TEXT
22. Bozzali M, Falini A, Franceschi M, et al. White matter damage in Alzheimer’s disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 2002;72:742-746.
FREE FULL TEXT
23. Takahashi S, Yonezawa H, Takahashi J, Kudo M, Inoue T, Tohgi H. Selective reduction of diffusion anisotropy in white matter of Alzheimer disease brains measured by 3.0 Tesla magnetic resonance imaging. Neurosci Lett. 2002;332:45-48.
FULL TEXT
|
ISI
| PUBMED
24. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet. 2001;357:169-175.
FULL TEXT
|
ISI
| PUBMED
RELATED ARTICLE
Age-Associated White Matter Lesions and Dementia: Are These Lesions Causal or Casual?
Gustavo C. Román
Arch Neurol. 2004;61(10):1503-1504.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Self-perceived memory impairment and cognitive performance in an elderly independent population with age-related white matter changes
Miranda et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:869-873.
ABSTRACT
| FULL TEXT
Vascular Subcortical Hyperintensities Predict Conversion to Vascular and Mixed Dementia in MCI Patients
Bombois et al.
Stroke 2008;39:2046-2051.
ABSTRACT
| FULL TEXT
Selective Reduction of Blood Flow to White Matter During Hypercapnia Corresponds With Leukoaraiosis
Mandell et al.
Stroke 2008;39:1993-1998.
ABSTRACT
| FULL TEXT
Unrecognized Myocardial Infarction in Relation to Risk of Dementia and Cerebral Small Vessel Disease
Ikram et al.
Stroke 2008;39:1421-1426.
ABSTRACT
| FULL TEXT
Leukoaraiosis: From an Ancient Term to an Actual Marker of Poor Prognosis
Pantoni
Stroke 2008;39:1401-1403.
FULL TEXT
Independent Cognitive Effects of Atrophy and Diffuse Subcortical and Thalamico-Cortical Cerebrovascular Disease in Dementia
Swartz et al.
Stroke 2008;39:822-830.
ABSTRACT
| FULL TEXT
Regional White Matter Pathology in Mild Cognitive Impairment: Differential Influence of Lesion Type on Neuropsychological Functioning
Delano-Wood et al.
Stroke 2008;39:794-799.
ABSTRACT
| FULL TEXT
Paradoxical embolisation and cerebral white matter lesions in dementia
Purandare et al.
Br. J. Radiol. 2008;81:30-34.
ABSTRACT
| FULL TEXT
Kidney Function Is Related to Cerebral Small Vessel Disease
Ikram et al.
Stroke 2008;39:55-61.
ABSTRACT
| FULL TEXT
White matter changes in dementia: does radiology matter?
BRONGE and WAHLUND
Br. J. Radiol. 2007;80:S115-S120.
ABSTRACT
| FULL TEXT
Biomarkers of cerebrovascular disease in dementia
MILLS et al.
Br. J. Radiol. 2007;80:S128-S145.
ABSTRACT
| FULL TEXT
Incidental Findings on Brain MRI in the General Population
Vernooij et al.
NEJM 2007;357:1821-1828.
ABSTRACT
| FULL TEXT
Subcortical Hyperintensities Are Associated With Cognitive Decline in Patients With Mild Cognitive Impairment
Debette et al.
Stroke 2007;38:2924-2930.
ABSTRACT
| FULL TEXT
Significant association between leukoaraiosis and metabolic syndrome in healthy subjects
Park et al.
Neurology 2007;69:974-978.
ABSTRACT
| FULL TEXT
Plasma folate concentration and cognitive performance: Rotterdam Scan Study
de Lau et al.
Am. J. Clin. Nutr. 2007;86:728-734.
ABSTRACT
| FULL TEXT
Modern concept of vascular cognitive impairment
Bowler
Br Med Bull 2007;83:291-305.
ABSTRACT
| FULL TEXT
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Authors/Task Force Members: et al.
Eur Heart J 2007;0:ehm236v1-75.
FULL TEXT
Association of Ambulatory Blood Pressure With Ischemic Brain Injury
Schwartz et al.
Hypertension 2007;49:1228-1234.
ABSTRACT
| FULL TEXT
Risk of Rapid Global Functional Decline in Elderly Patients With Severe Cerebral Age-Related White Matter Changes: The LADIS Study
Inzitari et al.
Arch Intern Med 2007;167:81-88.
ABSTRACT
| FULL TEXT
Clinically Silent Cerebral Ischemic Events After Cardiac Surgery: Their Incidence, Regional Vascular Occurrence, and Procedural Dependence
Floyd et al.
Ann. Thorac. Surg. 2006;81:2160-2166.
ABSTRACT
| FULL TEXT
White matter lesions and cognition: It's time for randomized trials to preserve intelligence
Hill and Mitchell
Neurology 2006;66:470-471.
FULL TEXT
MR spectroscopy of brain white matter in the prediction of dementia
den Heijer et al.
Neurology 2006;66:540-544.
ABSTRACT
| FULL TEXT
Retinal vessel diameters and cerebral small vessel disease: the Rotterdam Scan Study
Ikram et al.
Brain 2006;129:182-188.
ABSTRACT
| FULL TEXT
White Matter Lesions Are Prevalent but Differentially Related With Cognition in Aging and Early Alzheimer Disease
Burns et al.
Arch Neurol 2005;62:1870-1876.
ABSTRACT
| FULL TEXT
Age-Associated White Matter Lesions and Dementia: Are These Lesions Causal or Casual?
Roman
Arch Neurol 2004;61:1503-1504.
FULL TEXT
|
